Barbara Ma

844 total citations
17 papers, 648 citations indexed

About

Barbara Ma is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Barbara Ma has authored 17 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Barbara Ma's work include Immunotherapy and Immune Responses (12 papers), Cervical Cancer and HPV Research (7 papers) and Hepatitis B Virus Studies (6 papers). Barbara Ma is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), Cervical Cancer and HPV Research (7 papers) and Hepatitis B Virus Studies (6 papers). Barbara Ma collaborates with scholars based in United States, Taiwan and United Kingdom. Barbara Ma's co-authors include Chien‐Fu Hung, T.‐C. Wu, Archana Monie, T-C Wu, Ken Y. Lin, Anjui Wu, Yijie Xu, Chih-Long Chang, Xiaowu Pang and Niroshana Anandasabapathy and has published in prestigious journals such as Blood, Cancer and Journal of Investigative Dermatology.

In The Last Decade

Barbara Ma

16 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Ma United States	13	354	307	197	163	114	17	648
W Böhm Germany	10	454 1.3×	202 0.7×	175 0.9×	89 0.5×	69 0.6×	21	656
Ahmed Zafer Canada	12	501 1.4×	272 0.9×	112 0.6×	123 0.8×	56 0.5×	14	751
Klaus Zumbach Germany	10	168 0.5×	425 1.4×	86 0.4×	112 0.7×	81 0.7×	10	576
Adam R. Hersperger United States	12	657 1.9×	238 0.8×	127 0.6×	172 1.1×	75 0.7×	16	971
Natalija Budimir United States	16	847 2.4×	294 1.0×	268 1.4×	417 2.6×	33 0.3×	24	1.3k
Niladri Ganguly India	11	173 0.5×	220 0.7×	246 1.2×	137 0.8×	54 0.5×	19	621
Vera A. Tang Canada	13	186 0.5×	109 0.4×	252 1.3×	85 0.5×	70 0.6×	25	575
Carl E. Reid United States	10	97 0.3×	283 0.9×	225 1.1×	405 2.5×	112 1.0×	10	804
Raizy Gruda Israel	11	882 2.5×	206 0.7×	131 0.7×	228 1.4×	31 0.3×	11	1.1k
Megan E. Spurgeon United States	14	109 0.3×	240 0.8×	134 0.7×	465 2.9×	85 0.7×	21	748

Countries citing papers authored by Barbara Ma

Since Specialization

Citations

This map shows the geographic impact of Barbara Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Ma more than expected).

Fields of papers citing papers by Barbara Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Ma. The network helps show where Barbara Ma may publish in the future.

Co-authorship network of co-authors of Barbara Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Ma. A scholar is included among the top collaborators of Barbara Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Ma. Barbara Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Gribbin, Caitlin, Anna Alperovich, Barbara Ma, et al.. (2025). Real-world assessment of prophylactic anakinra on neurotoxicity after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysis. Blood. 146(Supplement 1). 712–712.

Ip, Andrew, Brittany Sinclaire, Michael Marafelias, et al.. (2023). The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real‐world, multicenter, retrospective study. Cancer. 129(12). 1885–1894. 6 indexed citations

Ramos, Alexander, Alexandra Giantini-Larsen, Susan C. Pannullo, et al.. (2022). A multidisciplinary management algorithm for brain metastases. Neuro-Oncology Advances. 4(1). vdac176–vdac176. 12 indexed citations

Ma, Barbara & Niroshana Anandasabapathy. (2021). Immune Checkpoint Blockade and Skin Toxicity Pathogenesis. Journal of Investigative Dermatology. 142(3). 951–959. 18 indexed citations

Ma, Barbara & Chaitra S. Ujjani. (2017). The clinical development of obinutuzumab for the treatment of follicular lymphoma. Cancer Management and Research. Volume 9. 103–113. 4 indexed citations

Kang, Tae Heung, Barbara Ma, Connie Wang, T.‐C. Wu, & Chien‐Fu Hung. (2012). Targeted Coating With Antigenic Peptide Renders Tumor Cells Susceptible to CD8+ T Cell-mediated Killing. Molecular Therapy. 21(3). 542–553. 14 indexed citations

Ma, Barbara, Bharat Maraj, Nam Phuong Tran, et al.. (2012). Emerging human papillomavirus vaccines. Expert Opinion on Emerging Drugs. 17(4). 469–492. 67 indexed citations

Kang, Tae Heung, et al.. (2011). LAH4 enhances CD8+ T cell immunity of protein/peptide-based vaccines. Vaccine. 30(4). 784–793. 38 indexed citations

Zeng, Qi, Bianca Gomez, Raphael P. Viscidi, et al.. (2011). Development of a DNA vaccine targeting Merkel cell polyomavirus. Vaccine. 30(7). 1322–1329. 50 indexed citations

10.

Peng, Shiwen, Barbara Ma, Shu‐Hsia Chen, Chien‐Fu Hung, & T-C Wu. (2011). DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunity. Cell & Bioscience. 1(1). 26–26. 5 indexed citations

11.

Yang, Huang‐Yu, et al.. (2011). Intraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumors. Cancer Immunology Immunotherapy. 60(8). 1085–1096. 14 indexed citations

12.

Lin, Ken Y., et al.. (2010). Therapeutic HPV DNA vaccines. Immunologic Research. 47(1-3). 86–112. 98 indexed citations

13.

Wu, Anjui, et al.. (2010). Immunotherapy for Cervical Cancer. BioDrugs. 24(2). 109–129. 90 indexed citations

14.

Ma, Barbara, Yijie Xu, Chien‐Fu Hung, & T.‐C. Wu. (2010). HPV and Therapeutic Vaccines: Where are We in 2010?. Current Cancer Therapy Reviews. 6(2). 81–103. 28 indexed citations

15.

Ma, Barbara, Richard B.S. Roden, & T.‐C. Wu. (2010). Current Status of Human Papillomavirus Vaccines. Journal of the Formosan Medical Association. 109(7). 481–483. 17 indexed citations

16.

Chang, Chih-Long, Barbara Ma, Xiaowu Pang, T.‐C. Wu, & Chien‐Fu Hung. (2009). Treatment With Cyclooxygenase-2 Inhibitors Enables Repeated Administration of Vaccinia Virus for Control of Ovarian Cancer. Molecular Therapy. 17(8). 1365–1372. 43 indexed citations

17.

Hung, Chien‐Fu, et al.. (2008). Therapeutic human papillomavirus vaccines: current clinical trials and future directions. Expert Opinion on Biological Therapy. 8(4). 421–439. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact